Laurus Labs is back in focus as the latest research update resets the stock's price target, putting fresh attention on what is driving the changing narrative around the company. With no prior target ...

SUNNYVALE, Calif., May 30, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of ...

Laurus Labs latest update leaves the fair value estimate at roughly ₹821.93 per share with a steady discount rate of 12.76%, underscoring that the market narrative is shifting more on expectations ...

Laurus Labs has seen a notable increase in its consensus analyst price target, which has risen from ₹724.14 to ₹815.86. This revision follows renewed analyst optimism, attributed largely to the ...

Laurus Labs has received a tentative nod from the Food and Drug Administration for Dolutegravir 5 mg and 10 mg for pediatric ARV treatment. This pediatric drug administration through oral dispersible ...

Laurus Labs share price rose over 2% during Monday's trading session to touch an 52-week high of ₹720.90 apiece on the BSE, marking the stock's third consecutive day of gains in a bullish trend. So ...

When Dr Satyanarayana Chava started Laurus Labs in 2007, he invested nearly Rs 60 crore of his own money into it. His confidence in its success was neither bravado nor bluster, but defined by his ...

LAURUS LABS LTD - Board Meeting Intimation for Inter-Alia To Consider The Un-Audited Financial Results Of The Company For The ...

The strategic alliance includes an initial seven high-value advanced intermediates and active pharmaceutical ingredients, including Willow's corticosteroid programs The agreement with Laurus is the ...